NEW YORK — Laboratory services firm LifeLabs said on Tuesday that it has partnered with Multiplex Genomics to perform SARS-CoV-2 testing and track virus variants in Canada.
Through the alliance, Toronto-based LifeLabs will provide SARS-CoV-2 test samples that Multiplex Genomics will analyze in order to confirm positive or negative results. Multiplex Genomics — a spinout of the University of Guelph's Centre for Biodiversity Genomics — will also sequence positive samples in order to assign them to SARS-CoV-2 variants.